Authors:
Bonanni, B
Johansson, H
Gandini, S
Guerrieri-Gonzaga, A
Torrisi, R
Sandri, MT
Cazzaniga, M
Mora, S
Robertson, C
Lien, EA
Decensi, A
Citation: B. Bonanni et al., Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women, BREAST CANC, 69(1), 2001, pp. 21-27
Authors:
Decensi, A
Torrisi, R
Bruno, S
Costantini, M
Curotto, A
Nicolo, G
Malcangi, B
Baglietto, L
Bruttini, GP
Gatteschi, B
Rondanina, G
Varaldo, M
Perloff, M
Malone, WF
Bruzzi, P
Citation: A. Decensi et al., Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point, CANC EPID B, 9(10), 2000, pp. 1071-1078
Authors:
Bruno, S
Torrisi, R
Costantini, M
Baglietto, L
Fontana, V
Gatteschi, B
Melioli, G
Nicolo, G
Curotto, A
Malcangi, B
Bruttini, GP
Varaldo, M
Bruzzi, P
Decensi, A
Citation: S. Bruno et al., Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial, J CELL BIOC, 76(2), 2000, pp. 311-321
Authors:
Baglietto, L
Torrisi, R
Arena, G
Tosetti, F
Gonzaga, AG
Pasquetti, W
Robertson, C
Decensi, A
Citation: L. Baglietto et al., Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer, CANCER DET, 24(4), 2000, pp. 369-375
Authors:
Torrisi, R
Mezzetti, M
Johansson, H
Barreca, A
Pigatto, F
Robertson, C
Decensi, A
Citation: R. Torrisi et al., Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-I, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial, INT J CANC, 87(4), 2000, pp. 601-605
Authors:
Decensi, A
Torrisi, R
Gozza, A
Severi, G
Bertelli, G
Fontana, V
Pensa, F
Carozzo, L
Traverso, A
Milone, S
Dini, D
Costa, A
Citation: A. Decensi et al., Effect of fenretinide on bone mineral density and metabolism in women withearly breast cancer, BREAST CANC, 53(2), 1999, pp. 145-151